Nifuroxazide CAS:965-52-6

Prevention and treatment of intestinal or urinary system diseases caused by Escherichia coli, Salmonella, Pasteurella (including riemannia), aerogenic bacteria, proteus, necrotizing bacteria and St...

Introduction

Prevention and treatment of intestinal or urinary system diseases caused by Escherichia coli, Salmonella, Pasteurella (including riemannia), aerogenic bacteria, proteus, necrotizing bacteria and Staphylococcus. It can effectively prevent diarrhea and promote animal feeding. Appearance Bright yellow crystalline powder Solubility Practically insoluble in water, slightly soluble in alcohol and practically insoluble in methylene chloride Loss on drying 0.5% Max Heavy metals(Pb) 0.002% Max Sulphated ash 0.1% Max Identification by IR The IR Spectrum confirms with the reference spectrum Related substance Impurity A ≤0.005%Impurity B ≤0.3%Impurity C ≤0.3%Impurity D ≤0.3%Impurity E ≤0.3%Signal unspecified impurities ≤0.1%Total impurities other than E ≤0.5%Total ≤0.5%Disregard limit ≤0.05% UV.Absorption The specific absorption at about 367nm is between 940-1000 Residual solvents Methanol ≤0.3%Alcohol ≤0.5% Acetic acid ≤0.5%NM ≤0.05% Assay (On dried) 98.5~101.5% Package: 25KG/drum or according to clients’ requirements. Storage: in a dry and ventilated warehouse; keep away from sunshine and moisture.,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

Inquiry

    Related Products